|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.435 USD | +2.14% |
|
-1.36% | -1.36% |
| Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
| Mar. 13 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from Russell Microcap Growth Index
| 1st Jan change | Capi. | |
|---|---|---|
| -1.36% | 75.72M | |
| -0.44% | 103B | |
| +3.10% | 96.73B | |
| +1.66% | 21.31B | |
| -16.32% | 21.21B | |
| -6.82% | 18.79B | |
| -41.41% | 16.37B | |
| -22.41% | 13.68B | |
| +6.20% | 13.44B | |
| +23.80% | 10.98B |
SPERO THERAPEUTICS, INC. 
